Pheast Therapeutics announced it raised $25.2 Million in an initial filing from an offering of $75.3 Million

Oct 28, 2022•about 3 years ago

Amount Raised

$25.2 Million

Redwood CityBiotechnology

Company Information

Company

Pheast Therapeutics

Location

200 Cardinal Way, Suite 300

Redwood City, California, United States

About

Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.

Related People

2 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Pheast Therapeutics announced it raised $25.2 Million in an initial filing from an offering of $75.3 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information